Fredericamycin derivatives

US8247424B2 · kind B2 · utility

Assignee

• Zentopharm GmbH · DE

Inventors

• Ulrich Abel · Schifferstadt, DE
• Werner Simon · Seeheim-Jugenheim, DE

Key dates

• Filing date: Mar 20, 2003
• Grant date: Aug 21, 2012
• Expiry date: Mar 20, 2023

Classification

• Technology area (CPC C): Chemistry; Metallurgy
• CPC primary: C07H15/26
• WIPO field: Pharmaceuticals
• WIPO sector: Chemistry

Abstract

The invention relates to novel fredericamycin derivatives, to drugs containing said derivatives or the salts thereof, and to the use of the fredericamycin derivatives for treating diseases, especially cancer diseases.